**Core Concept**
HbH disease is a type of alpha-thalassemia, characterized by the production of abnormal hemoglobin (HbH) due to mutations in the alpha-globin genes. This results from the deletion or mutation of one or more of the four alpha-globin gene copies, leading to reduced or absent production of the alpha-globin chains.

**Why the Correct Answer is Right**
In HbH disease, the reduction in alpha-globin production leads to a compensatory increase in the production of gamma-globin chains, resulting in the production of HbH (alpha4 delta 2). This abnormal hemoglobin is less effective at carrying oxygen and is more prone to degradation, leading to anemia, jaundice, and other complications. The correct answer is associated with this pathophysiological process.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because HbH disease is not primarily associated with beta-thalassemia, which involves mutations in the beta-globin genes.

**Option B:** This option is incorrect because HbH disease is not primarily associated with sickle cell disease, which involves mutations in the hemoglobin beta-globin gene that cause hemoglobin S (HbS) production.

**Option C:** This option is incorrect because HbH disease is not primarily associated with glucose-6-phosphate dehydrogenase (G6PD) deficiency, which is a condition that affects the red blood cell membrane and makes it more susceptible to oxidative stress.

**Clinical Pearl / High-Yield Fact**
A key feature of HbH disease is the presence of small, pale red blood cells with a characteristic "basket handle" appearance on peripheral smear, which can aid in diagnosis.

**Correct Answer: D**